Mike Quirk's most recent trade in Sage Therapeutics Inc was a trade of 36,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 36,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 24,999 | 0 (0%) | 0% | - | Common Stock | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 7,962 | 0 (0%) | 0% | - | Common Stock | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Jul 2025 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.22 per share. | 24 Jun 2025 | 113 | 30,461 (0%) | 0% | 9.2 | 1,042 | Common Stock |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 1,269 | 30,998 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 933 | 30,041 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Apr 2025 | 424 | 30,574 (0%) | 0% | 6.9 | 2,930 | Common Stock |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Apr 2025 | 312 | 29,729 (0%) | 0% | 6.9 | 2,156 | Common Stock |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 4,000 | 4,000 | - | - | S | |
| Sage Therapeutics Inc | Mike Quirk | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 2,000 | 29,108 (0%) | 0% | 0 | Common Stock |